Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.

Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation. - Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012422

Enrollment

Registered

2014-01-06

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Epoetin Beta 24000IU

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation. 2. Patients acquired informed consent about this study and fill in consent document after they gives sufficient explanation.

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity to Erythropoiesis-stimulating agents (Epoetin alfa,Epoetin beta, Darbepoetin alfa,Epoetin beta pegol) 2. Patients under 20 years old. 3. Patients judged inappropriate by attending physicians.

Design outcomes

Primary

Measure	Time frame
1.Volume of blood salvage by renal function. 2.Maintenance of perioperative period hemoglobin	—

Countries

Japan

Contacts

Public ContactMasaki kaibori

Kansai Medical University Surgery

kaibori@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026